Concepedia

Author

Lisa M. McShane

National Cancer InstituteORCID

Also Known As

Baron, John A., Catalina Valcárcel, James P. Solomon, Kevin Kalinsky, L M McShane, L McShane, L. M. McShane, L. M. Mcshane, L. McShane, L. Mcshane

388

Publications

56.1K

Citations

88

H-Index

187

Concepts

All Affiliations

National Cancer InstituteNational Institutes of HealthThe University of Texas MD Anderson Cancer CenterFrederick National Laboratory for Cancer ResearchMassachusetts General Hospital
LM

About

Lisa M. McShane is an author at National Cancer Institute specializing in medicine, pathology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

38

58

14.5K

2

Health Sciences

11

12

1.5K

3

Public Health

11

11

1.4K

4

Engineering

8

8

1.2K

5

Business

3

3

56

Lisa M. McShane

×

146

Publications

48K

Citations

74

H-Index

YearCitations

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz,

Journal of Clinical Oncology

2006

4.5K

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

M. Elizabeth H. Hammond, Daniel F. Hayes, Mitch Dowsett,

Journal of Clinical Oncology

2010

4.2K

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks,

Journal of Clinical Oncology

2013

4K

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Antonio C. Wolff, M. Elizabeth Hammond, Kimberly H. Allison,

Journal of Clinical Oncology

2018

2.3K

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei,

JNCI Journal of the National Cancer Institute

2005

2.1K

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

Christos Sotiriou, Soek-Ying Neo, Lisa M. McShane,

Proceedings of the National Academy of Sciences

2003

2K

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

M. Dowsett, Torsten O. Nielsen, Roger A’Hern,

JNCI Journal of the National Cancer Institute

2011

2K

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz,

Archives of Pathology & Laboratory Medicine

2007

1.8K

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks,

Archives of Pathology & Laboratory Medicine

2013

1.8K

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Antonio C. Wolff, M. Elizabeth Hammond, Kimberly H. Allison,

Archives of Pathology & Laboratory Medicine

2018

1.4K

Page 1